pyrroles has been researched along with melphalan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clingen, PH; De Silva, IU; Ghadessy, FJ; Hartley, JA; McHugh, PJ; Thurston, DE; Tilby, MJ | 1 |
Faivre, S; Hammel, P; Raymond, E; Ruszniewski, P | 1 |
2 other study(ies) available for pyrroles and melphalan
Article | Year |
---|---|
The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.
Topics: Animals; Antineoplastic Agents; Benzodiazepines; Benzodiazepinones; Cell Survival; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA Damage; DNA Repair; DNA-Binding Proteins; Endonucleases; Melphalan; Pyrroles; Recombination, Genetic | 2005 |
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoid Tumor; Cell Line, Tumor; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Indoles; Kidney Neoplasms; Lung Neoplasms; Melphalan; Neovascularization, Pathologic; Neuroendocrine Tumors; Pancreatic Neoplasms; Procarbazine; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Pyrroles; Sunitinib; Vinblastine; Xenograft Model Antitumor Assays | 2009 |